140 related articles for article (PubMed ID: 8188672)
1. Role of the carboxyl-terminal domains of the insulin and insulin-like growth factor I receptors in receptor function.
Faria TN; Blakesley VA; Kato H; Stannard B; LeRoith D; Roberts CT
J Biol Chem; 1994 May; 269(19):13922-8. PubMed ID: 8188672
[TBL] [Abstract][Full Text] [Related]
2. Signal transduction by a chimeric insulin-like growth factor-1 (IGF-1) receptor having the carboxyl-terminal domain of the insulin receptor.
Tartare S; Mothe I; Kowalski-Chauvel A; Breittmayer JP; Ballotti R; Van Obberghen E
J Biol Chem; 1994 Apr; 269(15):11449-55. PubMed ID: 8157675
[TBL] [Abstract][Full Text] [Related]
3. Essential role of tyrosine residues 1131, 1135, and 1136 of the insulin-like growth factor-I (IGF-I) receptor in IGF-I action.
Kato H; Faria TN; Stannard B; Roberts CT; LeRoith D
Mol Endocrinol; 1994 Jan; 8(1):40-50. PubMed ID: 7512194
[TBL] [Abstract][Full Text] [Related]
4. Tumorigenic and mitogenic capacities are reduced in transfected fibroblasts expressing mutant insulin-like growth factor (IGF)-I receptors. The role of tyrosine residues 1250, 1251, and 1316 in the carboxy-terminus of the IGF-I receptor.
Blakesley VA; Kalebic T; Helman LJ; Stannard B; Faria TN; Roberts CT; LeRoith D
Endocrinology; 1996 Feb; 137(2):410-7. PubMed ID: 8593783
[TBL] [Abstract][Full Text] [Related]
5. Tyrosine residues in the C-terminal domain of the insulin-like growth factor-I receptor mediate mitogenic and tumorigenic signals.
Esposito DL; Blakesley VA; Koval AP; Scrimgeour AG; LeRoith D
Endocrinology; 1997 Jul; 138(7):2979-88. PubMed ID: 9202243
[TBL] [Abstract][Full Text] [Related]
6. Role of tyrosine kinase activity in signal transduction by the insulin-like growth factor-I (IGF-I) receptor. Characterization of kinase-deficient IGF-I receptors and the action of an IGF-I-mimetic antibody (alpha IR-3).
Kato H; Faria TN; Stannard B; Roberts CT; LeRoith D
J Biol Chem; 1993 Feb; 268(4):2655-61. PubMed ID: 7679099
[TBL] [Abstract][Full Text] [Related]
7. Insulin and insulin-like growth factor-I receptors similarly stimulate deoxyribonucleic acid synthesis despite differences in cellular protein tyrosine phosphorylation.
Mastick CC; Kato H; Roberts CT; LeRoith D; Saltiel AR
Endocrinology; 1994 Jul; 135(1):214-22. PubMed ID: 7516864
[TBL] [Abstract][Full Text] [Related]
8. Mutational analysis of the mitogenic and transforming activities of the insulin-like growth factor I receptor.
Hongo A; D'Ambrosio C; Miura M; Morrione A; Baserga R
Oncogene; 1996 Mar; 12(6):1231-8. PubMed ID: 8649825
[TBL] [Abstract][Full Text] [Related]
9. Differences in signaling properties of the cytoplasmic domains of the insulin receptor and insulin-like growth factor receptor in 3T3-L1 adipocytes.
Ursø B; Cope DL; Kalloo-Hosein HE; Hayward AC; Whitehead JP; O'Rahilly S; Siddle K
J Biol Chem; 1999 Oct; 274(43):30864-73. PubMed ID: 10521479
[TBL] [Abstract][Full Text] [Related]
10. In IGF-I receptor-deficient leiomyosarcoma cells autocrine IGF-II induces cell invasion and protection from apoptosis via the insulin receptor isoform A.
Sciacca L; Mineo R; Pandini G; Murabito A; Vigneri R; Belfiore A
Oncogene; 2002 Nov; 21(54):8240-50. PubMed ID: 12447687
[TBL] [Abstract][Full Text] [Related]
11. Structure-function relationship of the insulin-like growth factor-I receptor tyrosine kinase.
Grønborg M; Wulff BS; Rasmussen JS; Kjeldsen T; Gammeltoft S
J Biol Chem; 1993 Nov; 268(31):23435-40. PubMed ID: 7693688
[TBL] [Abstract][Full Text] [Related]
12. Insulin and insulin-like growth factor-1 binding specificity is determined by distinct regions of their cognate receptors.
Schumacher R; Mosthaf L; Schlessinger J; Brandenburg D; Ullrich A
J Biol Chem; 1991 Oct; 266(29):19288-95. PubMed ID: 1655782
[TBL] [Abstract][Full Text] [Related]
13. Interaction of the molecular weight 85K regulatory subunit of the phosphatidylinositol 3-kinase with the insulin receptor and the insulin-like growth factor-1 (IGF- I) receptor: comparative study using the yeast two-hybrid system.
Tartare-Deckert S; Murdaca J; Sawka-Verhelle D; Holt KH; Pessin JE; Van Obberghen E
Endocrinology; 1996 Mar; 137(3):1019-24. PubMed ID: 8603569
[TBL] [Abstract][Full Text] [Related]
14. Paradoxical biological effects of overexpressed insulin-like growth factor-1 receptors in Chinese hamster ovary cells.
Kato H; Faria TN; Stannard B; Levy-Toledano R; Taylor SI; Roberts CT; LeRoith D
J Cell Physiol; 1993 Jul; 156(1):145-52. PubMed ID: 7686165
[TBL] [Abstract][Full Text] [Related]
15. The differential effects of pp120 (Ceacam 1) on the mitogenic action of insulin and insulin-like growth factor 1 are regulated by the nonconserved tyrosine 1316 in the insulin receptor.
Soni P; Lakkis M; Poy MN; Fernström MA; Najjar SM
Mol Cell Biol; 2000 Jun; 20(11):3896-905. PubMed ID: 10805733
[TBL] [Abstract][Full Text] [Related]
16. Characterization of insulin/IGF hybrid receptors: contributions of the insulin receptor L2 and Fn1 domains and the alternatively spliced exon 11 sequence to ligand binding and receptor activation.
Benyoucef S; Surinya KH; Hadaschik D; Siddle K
Biochem J; 2007 May; 403(3):603-13. PubMed ID: 17291192
[TBL] [Abstract][Full Text] [Related]
17. Mitogen-activated protein kinase and phosphatidylinositol 3-kinase pathways are not sufficient for insulin-like growth factor I-induced mitogenesis and tumorigenesis.
Scrimgeour AG; Blakesley VA; Stannard BS; LeRoith D
Endocrinology; 1997 Jun; 138(6):2552-8. PubMed ID: 9165048
[TBL] [Abstract][Full Text] [Related]
18. Mutation of a conserved amino acid residue (tryptophan 1173) in the tyrosine kinase domain of the IGF-I receptor abolishes autophosphorylation but does not eliminate biologic function.
Blakesley VA; Kato H; Roberts CT; LeRoith D
J Biol Chem; 1995 Feb; 270(6):2764-9. PubMed ID: 7852347
[TBL] [Abstract][Full Text] [Related]
19. Secretion of Annexin II via activation of insulin receptor and insulin-like growth factor receptor.
Zhao WQ; Chen GH; Chen H; Pascale A; Ravindranath L; Quon MJ; Alkon DL
J Biol Chem; 2003 Feb; 278(6):4205-15. PubMed ID: 12431980
[TBL] [Abstract][Full Text] [Related]
20. Single tyrosine substitution in the insulin-like growth factor I receptor inhibits ligand-induced receptor autophosphorylation and internalization, but not mitogenesis.
Stannard B; Blakesley V; Kato H; Roberts CT; LeRoith D
Endocrinology; 1995 Nov; 136(11):4918-24. PubMed ID: 7588225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
